Olon Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is POMALIDOMIDE, with a corresponding US DMF Number 30549.
Remarkably, this DMF maintains an Active status since its submission on May 10, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 08, 2017, and payment made on November 22, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II